Zhejiang Xinhua Chemical Co.,Ltd
SSE:603867.SS
23.98 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,965.729 | 2,596.604 | 2,683.362 | 2,554.824 | 2,321.141 | 1,717.988 | 2,232.216 | 2,026.706 | 1,591.259 | 1,328.218 | 1,542.094 |
| Cost of Revenue
| 2,350.008 | 1,992.706 | 2,050.874 | 2,085.973 | 1,825.961 | 1,313.604 | 1,748.623 | 1,643.733 | 1,285.495 | 1,076.426 | 1,332.827 |
| Gross Profit
| 615.72 | 603.898 | 632.488 | 468.851 | 495.18 | 404.383 | 483.592 | 382.973 | 305.764 | 251.792 | 209.268 |
| Gross Profit Ratio
| 0.208 | 0.233 | 0.236 | 0.184 | 0.213 | 0.235 | 0.217 | 0.189 | 0.192 | 0.19 | 0.136 |
| Reseach & Development Expenses
| 104.472 | 90.969 | 87.816 | 80.991 | 84.901 | 58.361 | 62.812 | 117.125 | 106.514 | 87.685 | 36.936 |
| General & Administrative Expenses
| 53.399 | 57.294 | 53.872 | 51.667 | 52.241 | 65.114 | -26.687 | -74.346 | -49.703 | 0.604 | 41.423 |
| Selling & Marketing Expenses
| 15.135 | 12.604 | 17.876 | 17.578 | 12.72 | 71.286 | 77.564 | 75.106 | 68.226 | 56.595 | 50.092 |
| SG&A
| 68.534 | 159.484 | 71.748 | 69.245 | 64.961 | 136.399 | 50.877 | 0.76 | 18.523 | 57.199 | 91.515 |
| Other Expenses
| 115.851 | 9.076 | 72.187 | 71.902 | 86.247 | 63.052 | 13.744 | 23.209 | 39.727 | 23.105 | 18.986 |
| Operating Expenses
| 288.857 | 263.047 | 231.751 | 222.138 | 236.11 | 257.812 | 243.982 | 216.216 | 210.911 | 178.606 | 162.072 |
| Operating Income
| 326.864 | 340.851 | 413.591 | 248.746 | 254.259 | 142.37 | 220.44 | 139.574 | 77.614 | 50.72 | 14.437 |
| Operating Income Ratio
| 0.11 | 0.131 | 0.154 | 0.097 | 0.11 | 0.083 | 0.099 | 0.069 | 0.049 | 0.038 | 0.009 |
| Total Other Income Expenses Net
| -7.694 | -3.129 | 3.363 | -6.643 | -2.27 | -0.016 | -2.588 | -0.858 | 24.188 | 23.122 | 18.75 |
| Income Before Tax
| 319.17 | 337.722 | 416.954 | 242.104 | 251.988 | 142.354 | 217.852 | 138.716 | 101.802 | 73.842 | 33.188 |
| Income Before Tax Ratio
| 0.108 | 0.13 | 0.155 | 0.095 | 0.109 | 0.083 | 0.098 | 0.068 | 0.064 | 0.056 | 0.022 |
| Income Tax Expense
| 44.291 | 48.947 | 47.346 | 31.85 | 29.292 | 16.129 | 29.111 | 21.089 | 16.756 | 8.468 | 0.175 |
| Net Income
| 226.914 | 252.62 | 329.227 | 196.818 | 205.548 | 123.495 | 174.536 | 118.819 | 84.319 | 65.07 | 35.251 |
| Net Income Ratio
| 0.077 | 0.097 | 0.123 | 0.077 | 0.089 | 0.072 | 0.078 | 0.059 | 0.053 | 0.049 | 0.023 |
| EPS
| 1.24 | 1.36 | 1.79 | 1.08 | 1.13 | 0.68 | 1.28 | 0.87 | 0.62 | 0.48 | 0.26 |
| EPS Diluted
| 1.17 | 1.33 | 1.78 | 1.08 | 1.13 | 0.68 | 1.28 | 0.87 | 0.62 | 0.48 | 0.26 |
| EBITDA
| 473.699 | 464.909 | 479.447 | 337.862 | 320.525 | 238.342 | 253.031 | 175.493 | 137.654 | 106.455 | 73.91 |
| EBITDA Ratio
| 0.16 | 0.179 | 0.179 | 0.132 | 0.138 | 0.139 | 0.113 | 0.087 | 0.087 | 0.08 | 0.048 |